¼ò½é£º
²¿·ÖÖÐÎı´Ç°ÁÐËØ´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©
Ó¢ÎÄÃû£ºberaprost
É̱êÃû£ºPROCYLIN
ÖÐÎÄÃû£º±´Ç°ÁÐËØƬ
Éú²úÉÌ£º¿ÆÑÐÑuËa
¥×¥í¥µ¥¤¥ê¥óåV20
ҩЧ·ÖÀà
¾¿ÚÇ°ÁÐÏÙËØI2ÓÕµ¼ÌåÖƼÁ
Åú×¼ÈÕÆÚ£º2012Äê12ÔÂ
É̘ËÃû
PROCYLIN Tablets 20
Ò»°ãÃû£º
¥Ù¥é¥×¥í¥¹¥È¥Ê¥È¥ê¥¦¥à (JAN) beraprost (INN)
»¯Ñ§Ãû£º
Monosodium (1RS , 2RS , 3aSR , 8bSR )-2, 3, 3a, 8b-tetrahydro-2-hydroxy-1-£Û(1E , 3SR , 4RS )-3-hydroxy-4-methyloct-1-en-6-yn-1-yl£Ý-1H -cyclopenta£Ûb £Ýbenzofuran-5-butanoate
Monosodium (1RS , 2RS , 3aSR , 8bSR )-2, 3, 3a, 8b-tetrahydro-2-hydroxy-1-£Û(1E , 3SR , 4SR )-3-hydroxy-4-methyloct-1-en-6-yn-1-yl£Ý-1H -cyclopenta£Ûb £Ýbenzofuran-5-butanoate
˜‹Ôìʽ£º
·Ö×Óʽ£º
C24H29NaO5
·Ö×ÓÁ¿£º
420.47
ÐÔ×´£º
±´ÀÆÕÀ˹ÌØÄÆÊÇ°×É«·ÛÄ©¡£
¼«Ò×Èܽâ¼×´¼£¬Ò×ÈÜÓÚË®»òÒÒ´¼(99.5)ÖС£
ÎüʪÐÔ¡£
Ë®ÈÜÒº(1→200)²»ÏÔʾÐý¹âÐÔ¡£
·ÖÅäϵÊý(1-°Ë´¼/ˮϵ)£º
460 (pH3)¡¢15 (pH7)¡¢0.41 (pH9)
Ò©Àíѧ
¿¹ÑªÐ¡°å×÷ÓÃ
ÔÚ¸øÄ©ÉÒÑ»·ÕÏ°»¼Õß¼°½¡¿µ³ÉÈ˵ĿڷþÖÐÒÖÖÆѪС°åÄý¼¯Äܼ°ÑªÐ¡°åÕ³×ÅÄÜ¡£
ÒÖÖÆÒòÄý¼¯ÓÕ·¢ÎïÖÊÒýÆðµÄÈËѪС°åÄý¼¯£¬¾ßÓÐÈËѪС°åÄý¼¯¿é½âÀë×÷ÓÃ(in vitro )¡£
Ѫ¹ÜÀ©ÕźÍѪÁ÷Ôö¼ÓµÄ×÷ÓÃ
ͨ¹ý¸ø½¡¿µ³ÉÈ˵ĿڷþÒ©¿ÉÒÔÔö¼ÓƤ·ôѪҺÁ÷Á¿¡£
ÔÚ¸øÄ©ÉÒÑ»·ÕÏ°»¼ÕߵĿڷþÒ©ÖУ¬³ÐÈÏÁËÓÉÓڽű³Æ¤Ïµİ²¾²Ê±×éÖ¯Ñõ·ÖѹµÄÉÏÉýºÍÇý¶¯Ñª»Ö¸´Ê±¼äµÄËõ¶Ì13)ÒÔ¼°¼¤¹â¶àÆÕÀÕ·¨µÄƤ·ôѪÁ÷Á¿µÄÔö¼Ó¡£
¶Ôͨ¹ýK+¡¢PGF2αʹ֮ÊÕËõÁ˵Ĺ·µÄ´óÍȶ¯Âö¡¢³¦¼äĤ¶¯ÂöµÈ¡¢¸÷ÖÖÕª³ö¶¯Âö¼°ÑªÇåËØ¡¢ëèÄáÁÐÄþʹ֮ÊÕËõÁ˵Ĺ·µÄÕª³ö·Î¶¯Âö±íʾËɳÚ×÷ÓÃ(in vitro )£¬Ê¹¹·µÄ¸÷ÖÖÄÚÔàÆ÷¹ÙѪ¹ÜµÄѪÁ÷Ôö¼Ó¡£
Ѫ¹Üƽ»¬¼¡Ï¸°ûÔöÖ³ÒÖÖÆ×÷ÓÃ
ÒÖÖÆÓÉÓÚѪС°åÀ´Ô´ÔöÖ³Òò×Ӵ̼¤µÄÈ˷ζ¯ÂöѪ¹Üƽ»¬¼¡Ï¸°ûµÄÔöÖ³(in vitro )¡£
¶Ô²¡Ì¬Ä£Ð͵Ä×÷ÓÃ
ÂýÐÔ¶¯Âö±ÕÈûÖ¢
¶ÔÀÎÚÁÖËáÓÕ·¢ÀÏÊóºóÖ«Ñ»·ÕÏ°¡¢°¬¶û¸ê°·-ÉöÉÏÏÙËØÓÕ·¢ÀÏÊóβѻ·ÕÏ°¼°µç´Ì¼¤ÓÕ·¢Íö¯ÂöѪ˨£¬ÒÖÖÆȱѪÐÔ²¡±äµÄ½øÕ¹»òѪ˨Ðγɡ£
Ѫ˨֢״
¶ÔÀÏÊó¶¯ÂöѪ˨֢¼°ÀÏÊó¾²ÂöѪ˨֢µÈ¾ßÓÐÒÖÖÆѪ˨ÐγɵÄЧ¹û¡£
Ƥ·ôÀ£ÑñÄ£ÐÍ
¶ÔÀÏÊó´×ËáƤ·ôÀ£Ññ£¬±íʾÖÎÁÆ´Ù½øЧ¹û¡£
·Î¸ßѪѹ֢
ÔÚµ¥É«°·ÓÕ·¢ÀÏÊó·Î¸ßѪѹģÐÍÖУ¬¾¿Ú·þÓÿÉÒÖÖÆÓÒÊÒÊÕËõÆÚѹµÄÉÏÉý¼°·ÎѪ¹ÜÖÐĤ¼¡ÐÔ·Ê´ó.
ÔÚ¶àÂ׶àbokisanagonistÓÕ·¢¹··Î¸ßѪѹģÐÍÖУ¬Í¨¹ý¾²Âö×¢Éäʹ·Î¶¯Âöѹ¼°·ÎѪ¹Ü×èÁ¦Ï½µ¡£
×èÈûÓÕ·¢ÀÏÊó·Î¸ßѪѹģÐÍÒÖÖÆÓÒÊÒÊÕËõÆÚѹÉÏÉý¡£
×÷ÓÙCÐò
±¾¼Á¾ÓÉѪС°å¼°Ñª¹Üƽ»¬½îµÄ¼ÄÉúËØI2ÈÝÄÉÌ壬ÓëÇ°ÁÐÏÙËØI2ͬÑùµØ»îÐÔ»¯ÏÙÜÕø£¬Í¨¹ýϸ°ûÄÚcAMPŨ¶ÈÉÏÉý¡¢Ca2+Á÷ÈëÒÖÖƼ°¶àÂ׶಩¿ËɽA2Éú³ÉÒÖÖƵȱíʾ¿¹ÑªÐ¡°å×÷Óü°Ñª¹ÜÀ©ÕÅ×÷Óõȡ£
ÊÊÓ¦Ö¢
¡ðÂýÐÔ¶¯Âö±ÕÈûÖ¢°éËæµÄÀ£Ññ¡¢ÌÛÍ´¼°Àä¸ÐµÄ¸ÄÉÆ¡£
¡ðÔ·¢ÐԷθßѪˆRÖ¢
Ó÷¨ÓëÓÃÁ¿
¡ðÂýÐÔ¶¯Âö±ÕÈûÖ¢°éËæµÄÀ£Ññ¡¢ÌÛÍ´¼°Àä¸ÐµÄ¸ÄÉÆ¡£
³ÉÈË£¬×÷Ϊberapurosutorinumu£¬1Ìì120μg·Ö3´Î·¹ºó¾¿Ú·þÓá£
¡ðÔ·¢ÐԷθßѪˆRÖ¢
ͨ³££¬³ÉÈË£¬×÷Ϊberapurosutorinumu£¬´Ó1ÈÕ°Ñ60μg·Ö³É3´ÎÔÚ·¹ºó¿Ú·þÓõÄÊ¿ªÊ¼£¬³ä·ÖÒ»±ß¹Û²ìÖ¢×´(¸±×÷ÓÃ)Ò»±ßÖð½¥ÔöÁ¿¡£ÔÚÔö¼ÓÁ¿Ê±£¬Ã¿ÌìʹÓôÎÊýΪ3¡«4´Î£¬×î¸ßÓÃÁ¿Îª180μg¡£
ÁÙ´²³É¼¨
¡ðÂýÐÔ¶¯Âö±ÕÈûÖ¢°éËæµÄÀ£Ññ¡¢ÌÛÍ´¼°Àä¸ÐµÄ¸ÄÉÆ
ͨ¹ý¶ÔÂýÐÔ¶¯Âö±ÕÈûÖ¢µÄË«ÖØä¼ì±È½ÏÊÔÑ飬ȷÈÏÁ˱¾¼ÁµÄÓÐÓÃÐÔ¡£ÔÚ°üº¬Ë«Ã¤¼ìÑé±È½ÏÊÔÑéµÄ×ܼÆ205Àý×ÓµÄÁÙ´²ÊÔÑéÖУ¬¶ÔÀ£Ññ£¬ÌÛÍ´¼°Àä¸ÐµÈµÄÐéѪÐÔÖîÖ¢×´µÄ¸ÄÉƶȣ¬ÊÇÖеȶȸÄÉÆÒÔÉÏ63.9£¥(131Àý)£¬Çá¶È¸ÄÉÆÒÔÉÏ82.9£¥(170Àý)¡£
¡ðÔ·¢ÐԷθßѪˆRÖ¢
ÔڶԷθßѪѹ֢µÄ¶àÉèÊ©¿ª·ÅÊÔÑéÖУ¬ºËµçÕ¾ÐԷθßѪѹ֢21ÀýÖеÄÈ«·ÎѪ¹ÜµÖ¿¹µÈµÄÐÄѪÐж¯Ì¬Ö¸±ê¼°×ÔËû¾õ¹Û²ìµÈ×ۺϵÄ×îÖÕÕûÌå¸ÄÉƶȣ¬ÊÇÖеȶȸÄÉÆÒÔÉÏ38.1%(8Àý)£¬Çá¶È¸ÄÉÆÒÔÉÏ61.9%(13Àý)¡£
°ü×°
(PTP) 100åV (10åV×10)¡¢500åV (10åV×50)¡¢1,000åV (10åV×100)¡¢1,050åV (21åV×50)
(¥×¥é¥¹¥Á¥Ã¥¯ÈÝÆ÷) 500åV
³§¼Ò
¿ÆÑÐÖÆÒ©Öêʽ»áÉç
×¢£ºÒÔÉÏÖÐÎÄ×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ×ÊÁÏΪ׼¡£
ÍêÕû´¦·½×ÊÁϸ½¼þ£º
http://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/200022_3399005F1030_1_18
Procylin
Procylin may be available in the countries listed below.
Ingredient matches for Procylin
Beraprost
Beraprost sodium (a derivative of Beraprost) is reported as an ingredient of Procylin in the following countries:
•Japan
|